These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7905714)
1. Interaction of rat kidney P-glycoprotein with a urinary component and various drugs including cyclosporin A. Charuk JH; Loo TW; Clarke DM; Reithmeier RA Am J Physiol; 1994 Jan; 266(1 Pt 2):F66-75. PubMed ID: 7905714 [TBL] [Abstract][Full Text] [Related]
2. Differential interaction of human renal P-glycoprotein with various metabolites and analogues of cyclosporin A. Charuk JH; Wong PY; Reithmeier RA Am J Physiol; 1995 Jul; 269(1 Pt 2):F31-9. PubMed ID: 7631829 [TBL] [Abstract][Full Text] [Related]
3. Interaction of P-glycoprotein with a hydrophobic component of rat urine. Charuk JH; Reithmeier RA Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. De Lannoy IA; Koren G; Klein J; Charuk J; Silverman M Am J Physiol; 1992 Oct; 263(4 Pt 2):F613-22. PubMed ID: 1357987 [TBL] [Abstract][Full Text] [Related]
5. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Zordan-Nudo T; Ling V; Liu Z; Georges E Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver. Stapf V; Thalhammer T; Huber-Huber R; Felberbauer F; Gajdzik L; Graf J Anticancer Res; 1994; 14(2A):581-5. PubMed ID: 7912496 [TBL] [Abstract][Full Text] [Related]
7. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378 [TBL] [Abstract][Full Text] [Related]
8. Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell. Ichikawa M; Yoshimura A; Sumizawa T; Shudo N; Kuwazuru Y; Furukawa T; Akiyama S J Biol Chem; 1991 Jan; 266(2):903-8. PubMed ID: 1670776 [TBL] [Abstract][Full Text] [Related]
9. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney. Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797 [TBL] [Abstract][Full Text] [Related]
10. Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport. Thalhammer T; Stapf V; Gajdzik L; Graf J Eur J Pharmacol; 1994 Apr; 270(2-3):213-20. PubMed ID: 7913684 [TBL] [Abstract][Full Text] [Related]
11. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. Tamai I; Safa AR J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434 [TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Safa AR Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250 [TBL] [Abstract][Full Text] [Related]
14. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. Safa AR; Glover CJ; Sewell JL; Meyers MB; Biedler JL; Felsted RL J Biol Chem; 1987 Jun; 262(16):7884-8. PubMed ID: 3034908 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Jetté L; Beaulieu E; Leclerc JM; Béliveau R Am J Physiol; 1996 May; 270(5 Pt 2):F756-65. PubMed ID: 8928836 [TBL] [Abstract][Full Text] [Related]
16. Identification of the synthetic surfactant nonylphenol ethoxylate: a P-glycoprotein substrate in human urine. Charuk MH; Grey AA; Reithmeier RA Am J Physiol; 1998 Jun; 274(6):F1127-39. PubMed ID: 9841506 [TBL] [Abstract][Full Text] [Related]
17. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment. Jetté L; Murphy GF; Béliveau R Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733 [TBL] [Abstract][Full Text] [Related]
18. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells. Naito M; Tsuruo T Biochem Biophys Res Commun; 1992 May; 185(1):284-90. PubMed ID: 1350903 [TBL] [Abstract][Full Text] [Related]
19. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Horio M; Lovelace E; Pastan I; Gottesman MM Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642 [TBL] [Abstract][Full Text] [Related]
20. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. Hori R; Okamura N; Aiba T; Tanigawara Y J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]